CRISPR/Cas9 technology generated an A to G (c.1337A>G) change resulting in a tyrosine to cysteine substitution at amino acid 446 (p.Y446C) in exon 14. This is a mutation reported as the genetic cause of Pierpont Syndrome. (J:335355)
查看原文 参与反馈
CRISPR/Cas9 technology generated an A to G (c.1337A>G) change resulting in a tyrosine to cysteine substitution at amino acid 446 (p.Y446C) in exon 14. This is a mutation reported as the genetic cause of Pierpont Syndrome. (J:335355)